SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-006594
Filing Date
2024-05-03
Accepted
2024-05-03 08:00:13
Documents
17
Period of Report
2024-05-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrmy-20240501x8k.htm   iXBRL 8-K 42840
2 EX-10.1 hrmy-20240501xex10d1.htm EX-10.1 44571
3 GRAPHIC hrmy-20240501x8k001.jpg GRAPHIC 1167
4 GRAPHIC hrmy-20240501xex10d1001.jpg GRAPHIC 6592
5 GRAPHIC hrmy-20240501xex10d1002.jpg GRAPHIC 7757
  Complete submission text file 0001558370-24-006594.txt   238799

Data Files

Seq Description Document Type Size
6 EX-101.SCH hrmy-20240501.xsd EX-101.SCH 3162
7 EX-101.LAB hrmy-20240501_lab.xml EX-101.LAB 15927
8 EX-101.PRE hrmy-20240501_pre.xml EX-101.PRE 10080
20 EXTRACTED XBRL INSTANCE DOCUMENT hrmy-20240501x8k_htm.xml XML 4831
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

IRS No.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39450 | Film No.: 24910825
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)